Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 5,879,000 | 5,604,000 | 5,685,000 | 5,281,000 | 5,795,000 |
| Cost of Goods | 1,683,000 | 1,035,000 | 1,000,000 | 957,000 | 1,570,000 |
| Gross Profit | 4,196,000 | 4,569,000 | 4,685,000 | 4,324,000 | 4,225,000 |
| Operating Expenses | 3,103,000 | 6,042,000 | 2,255,000 | 2,087,000 | 3,081,000 |
| Operating Income | 1,093,000 | -1,473,000 | 2,430,000 | 2,237,000 | 1,144,000 |
| Interest Expense | 243,000 | 250,000 | 248,000 | 254,000 | 257,000 |
| Other Income | 1,051,000 | 222,000 | 228,000 | 367,000 | 129,000 |
| Pre-tax Income | 1,901,000 | -1,501,000 | 2,410,000 | 2,350,000 | 1,016,000 |
| Income Tax | -788,000 | -333,000 | 535,000 | 382,000 | 1,013,000 |
| Net Income Continuous | 2,689,000 | -1,168,000 | 1,875,000 | 1,968,000 | 3,000 |
| Minority Interests | -7,000 | -3,000 | -5,000 | -7,000 | N/A |
| Net Income | $2,696,000 | $-1,165,000 | $1,880,000 | $1,975,000 | $3,000 |
| EPS Basic Total Ops | 2.13 | -0.92 | 1.48 | 1.55 | N/A |
| EPS Basic Continuous Ops | 2.13 | -0.92 | 1.47 | 1.54 | 0.01 |
| EPS Diluted Total Ops | 2.13 | -0.92 | 1.47 | 1.54 | 0.01 |
| EPS Diluted Continuous Ops | 2.12 | -0.92 | 1.47 | 1.53 | 0.01 |
| EBITDA(a) | $1,443,000 | $-1,126,000 | $2,778,000 | $2,596,000 | $1,502,000 |